Gastric-retained pharmaceutical composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 9/00 (2006.01) A61K 9/46 (2006.01) A61K 31/166 (2006.01)

Patent

CA 2286081

The invention concerns a gastric-retained pharmaceutical composition, characterised in that it comprises: (a) an active principle consisting in a benzamide or a benzamide salt; (b) a system for generating carbon dioxide; and (c) means for partially retaining the carbon dioxide generated by the carbon dioxide generating means.

Composition pharmaceutique à résidence gastrique, caractérisée en ce qu'elle comprend: (a) un principe actif consistant en un benzamide ou un sel de benzamide, (b) un système générateur de dioxyde de carbone, et (c) un moyen permettant la rétention partielle du dioxyde de carbone généré par ledit système générateur de dioxyde de carbone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gastric-retained pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gastric-retained pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastric-retained pharmaceutical composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1962397

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.